Cano Health Inc CANO shares are trading lower by 34.13% to $2.20 Thursday morning after the company reported worse-than-expected third-quarter EPS and sales results.
What Happened?
Cano Health reported quarterly losses of 23 cents per share which missed the analyst consensus estimate of a loss of 5 cents by 360 percent. The company reported quarterly sales of $665.00 million which missed the analyst consensus estimate of $717.93 million by 7%. This is a 26% increase over sales of $526.80 million in the same period last year.
Among other highlights provided by Cano:
- Total membership of 294,596, including 168,346 Medicare capitated members, an increase of 40% year-over-year for both
- Net loss of $(112.0) million, unfavorably impacted by a $65.7 million fair value adjustment of warrant liabilities
- Adjusted EBITDA of $42.5 million, compared to $13.6 million in the third quarter of 2021, an increase of 211% year over year
According to data from Benzinga Pro, CANO has a 52-week high of $12.87 and a 52-week low of $2.05.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
